Kern W - Search Results

1

Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative Group.

Kern W, Aul C, Maschmeyer G, Kuse R, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W. Kern W, et al. Ann Hematol. 1998 Sep;77(3):115-22. doi: 10.1007/s002770050425. Ann Hematol. 1998. PMID: 9797080 Clinical Trial.

2

Prevention of infection in acute leukemia.

Maschmeyer G, Daenen S, de Pauw BE, de Vries-Hospers HG, Dekker AW, Donnelly JP, Gaus W, Haralambie E, Kern W, Konrad H, et al. Maschmeyer G, et al. Among authors: kern w. Haematol Blood Transfus. 1990;33:525-30. doi: 10.1007/978-3-642-74643-7_94. Haematol Blood Transfus. 1990. PMID: 2108911 Review.

3

Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.

Maschmeyer G, Haralambie E, Gaus W, Kern W, Dekker AW, De Vries-Hospers HG, Sizoo W, König W, Gutzler F, Daenen S. Maschmeyer G, et al. Among authors: kern w. Infection. 1988 Mar-Apr;16(2):98-104. doi: 10.1007/BF01644312. Infection. 1988. PMID: 3286509 Clinical Trial.

4

Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve.

Schleyer E, Kühn S, Rührs H, Unterhalt M, Kaufmann CC, Kern W, Braess J, Sträubel G, Hiddemann W. Schleyer E, et al. Among authors: kern w. Leukemia. 1996 Apr;10(4):707-12. Leukemia. 1996. PMID: 8618451 Clinical Trial.

5

Optimizing therapy for acute myeloid leukemia based on differences in intracellular metabolism of cytosine arabinoside between leukemic blasts and normal mononuclear blood cells.

Hiddemann W, Schleyer E, Unterhalt M, Kern W, Büchner T. Hiddemann W, et al. Among authors: kern w. Ther Drug Monit. 1996 Aug;18(4):341-9. doi: 10.1097/00007691-199608000-00005. Ther Drug Monit. 1996. PMID: 8857548

6

Response to cytarabine ocfosfate (YNK01) in a patient with chronic lymphocytic leukemia refractory to treatment with chlorambucil/prednisone, fludarabine, and prednimustine/mitoxantrone.

Braess J, Kern W, Unterhalt M, Kaufmann CC, Ramsauer B, Schüssler M, Kaeser-Fröhlich A, Hiddemann W, Schleyer E. Braess J, et al. Among authors: kern w. Ann Hematol. 1996 Oct;73(4):201-4. doi: 10.1007/s002770050229. Ann Hematol. 1996. PMID: 8890711 Clinical Trial.

7

High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II study.

Kern W, Schleyer E, Unterhalt M, Wörmann B, Büchner T, Hiddemann W. Kern W, et al. Cancer. 1997 Jan 1;79(1):59-68. Cancer. 1997. PMID: 8988727

8

Frequency and causes of refractoriness in multiply transfused patients.

Legler TJ, Fischer I, Dittmann J, Simson G, Lynen R, Humpe A, Riggert J, Schleyer E, Kern W, Hiddemann W, Köhler M. Legler TJ, et al. Among authors: kern w. Ann Hematol. 1997 Apr;74(4):185-9. doi: 10.1007/s002770050280. Ann Hematol. 1997. PMID: 9174547

9

Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve.

Schleyer E, Kühn S, Rührs H, Unterhalt M, Kaufmann CC, Kern W, Braess J, Sträubel G, Hiddemann W. Schleyer E, et al. Among authors: kern w. Leukemia. 1997 Dec;11 Suppl 5:S15-21. Leukemia. 1997. PMID: 9436933

10

Chronic systemic aspergillosis in a patient with acute myeloid leukemia.

Kern W, Braess J, Bertz H, Pott C, Schleyer E, Finke J, Rüchel R, Hiddemann W. Kern W, et al. Ann Hematol. 1998 Mar-Apr;76(3-4):175-7. doi: 10.1007/s002770050383. Ann Hematol. 1998. PMID: 9619736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,210 results

Search Page

Filters